InstitutionMD Anderson
DepartmentMolecular & Cellular Oncology
Address6767 Bertner St
Houston TX 77030-2603
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Saldarriaga OA, Wanninger TG, Arroyave E, Gosnell J, Krishnan S, Oneka M, Bao D, Millian DE, Kueht ML, Moghe A, Jiao J, Sanchez JI, Spratt H, Beretta L, Rao A, Burks JK, Stevenson HL. Heterogeneity in intrahepatic macrophage populations and druggable target expression in patients with steatotic liver disease-related fibrosis. JHEP Rep. 2024 Jan; 6(1):100958. PMID: 38162144; PMCID: PMC10757256.
    2. Engel BJ, Paolillo V, Uddin MN, Gonzales KA, McGinnis KM, Sutton MN, Patnana M, Grindel BJ, Gores GJ, Piwnica-Worms D, Beretta L, Pisaneschi F, Gammon ST, Millward SW. Gender Differences in a Mouse Model of Hepatocellular Carcinoma Revealed Using Multi-Modal Imaging. Cancers (Basel). 2023 Jul 26; 15(15). PMID: 37568603; PMCID: PMC10417617.
    3. Zhang Y, Zhao Z, Huang LA, Liu Y, Yao J, Sun C, Li Y, Zhang Z, Ye Y, Yuan F, Nguyen TK, Garlapati NR, Wu A, Egranov SD, Caudle AS, Sahin AA, Lim B, Beretta L, Calin GA, Yu D, Hung MC, Curran MA, Rezvani K, Gan B, Tan Z, Han L, Lin C, Yang L. Molecular mechanisms of snoRNA-IL-15 crosstalk in adipocyte lipolysis and NK cell rejuvenation. Cell Metab. 2023 08 08; 35(8):1457-1473.e13. PMID: 37329887; PMCID: PMC10712687.
      Citations: 1     Fields:    Translation:AnimalsCells
    4. Sanchez JI, Parra ER, Jiao J, Solis Soto LM, Ledesma DA, Saldarriaga OA, Stevenson HL, Beretta L. Cellular and Molecular Mechanisms of Liver Fibrosis in Patients with NAFLD. Cancers (Basel). 2023 May 23; 15(11). PMID: 37296834; PMCID: PMC10252068.
    5. Saldarriaga OA, Krishnan S, Wanninger TG, Oneka M, Rao A, Bao D, Arroyave E, Gosnell J, Kueht M, Moghe A, Millian D, Jiao J, Sanchez JI, Spratt H, Beretta L, Stevenson HL. Patients with fibrosis from non-alcoholic steatohepatitis have heterogeneous intrahepatic macrophages and therapeutic targets. medRxiv. 2023 Feb 23. PMID: 36865099; PMCID: PMC9980226.
    6. Kwan SY, Slayden AN, Coronado AR, Marquez RC, Chen H, Wei P, Savage MI, Vornik LA, Fox JT, Sei S, Liang D, Stevenson HL, Wilkerson GK, Gagea M, Brown PH, Beretta L. Treatment Strategies and Mechanisms Associated with the Prevention of NASH-Associated HCC by a Toll-like Receptor 4 Inhibitor. Cancer Prev Res (Phila). 2023 01 04; 16(1):17-28. PMID: 36162136; PMCID: PMC9812917.
      Citations: 1     Fields:    Translation:AnimalsCells
    7. Jiao J, Sanchez JI, Saldarriaga OA, Solis LM, Tweardy DJ, Maru DM, Stevenson HL, Beretta L. Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease. JHEP Rep. 2023 Feb; 5(2):100628. PMID: 36687470; PMCID: PMC9850198.
      Citations: 3     
    8. Sabotta CM, Kwan SY, Petty LE, Below JE, Joon A, Wei P, Fisher-Hoch SP, McCormick JB, Beretta L. Genetic variants associated with circulating liver injury markers in Mexican Americans, a population at risk for non-alcoholic fatty liver disease. Front Genet. 2022; 13:995488. PMID: 36386790; PMCID: PMC9644071.
    9. Kwan SY, Sabotta CM, Joon A, Wei P, Petty LE, Below JE, Wu X, Zhang J, Jenq RR, Hawk ET, McCormick JB, Fisher-Hoch SP, Beretta L. Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas. mSystems. 2022 06 28; 7(3):e0003322. PMID: 35477306; PMCID: PMC9238400.
    10. Kaseb AO, Hasanov E, Cao HST, Xiao L, Vauthey JN, Lee SS, Yavuz BG, Mohamed YI, Qayyum A, Jindal S, Duan F, Basu S, Yadav SS, Nicholas C, Sun JJ, Singh Raghav KP, Rashid A, Carter K, Chun YS, Tzeng CD, Sakamuri D, Xu L, Sun R, Cristini V, Beretta L, Yao JC, Wolff RA, Allison JP, Sharma P. Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial. Lancet Gastroenterol Hepatol. 2022 03; 7(3):208-218. PMID: 35065057; PMCID: PMC8840977.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    11. Kwan SY, Jiao J, Joon A, Wei P, Petty LE, Below JE, Daniel CR, Wu X, Zhang J, Jenq RR, Futreal PA, Hawk ET, McCormick JB, Fisher-Hoch SP, Beretta L. Gut microbiome features associated with liver fibrosis in Hispanics, a population at high risk for fatty liver disease. Hepatology. 2022 04; 75(4):955-967. PMID: 34633706; PMCID: PMC8930512.
      Citations: 3     Fields:    Translation:HumansCells
    12. Sanchez JI, Jiao J, Kwan SY, Veillon L, Warmoes MO, Tan L, Odewole M, Rich NE, Wei P, Lorenzi PL, Singal AG, Beretta L. Lipidomic Profiles of Plasma Exosomes Identify Candidate Biomarkers for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis. Cancer Prev Res (Phila). 2021 10; 14(10):955-962. PMID: 34253566; PMCID: PMC8546639.
      Citations: 3     Fields:    Translation:HumansCells
    13. Jiao J, Sanchez JI, Thompson EJ, Mao X, McCormick JB, Fisher-Hoch SP, Futreal PA, Zhang J, Beretta L. Somatic Mutations in Circulating Cell-Free DNA and Risk for Hepatocellular Carcinoma in Hispanics. Int J Mol Sci. 2021 Jul 10; 22(14). PMID: 34299031; PMCID: PMC8304329.
      Citations: 1     Fields:    Translation:Humans
    14. Jiao J, Kwan SY, Sabotta CM, Tanaka H, Veillon L, Warmoes MO, Lorenzi PL, Wang Y, Wei P, Hawk ET, Almeda JL, McCormick JB, Fisher-Hoch SP, Beretta L. Circulating Fatty Acids Associated with Advanced Liver Fibrosis and Hepatocellular Carcinoma in South Texas Hispanics. Cancer Epidemiol Biomarkers Prev. 2021 09; 30(9):1643-1651. PMID: 34155064; PMCID: PMC8419070.
      Citations:    Fields:    Translation:Humans
    15. Khan IM, Gjuka D, Jiao J, Song X, Wang Y, Wang J, Wei P, El-Serag HB, Marrero JA, Beretta L. A Novel Biomarker Panel for the Early Detection and Risk Assessment of Hepatocellular Carcinoma in Patients with Cirrhosis. Cancer Prev Res (Phila). 2021 06; 14(6):667-674. PMID: 33685927; PMCID: PMC8225562.
      Citations: 2     Fields:    Translation:Humans
    16. Watt GP, De La Cerda I, Pan JJ, Fallon MB, Beretta L, Loomba R, Lee M, McCormick JB, Fisher-Hoch SP. Elevated Glycated Hemoglobin Is Associated With Liver Fibrosis, as Assessed by Elastography, in a Population-Based Study of Mexican Americans. Hepatol Commun. 2020 Dec; 4(12):1793-1801. PMID: 33305150; PMCID: PMC7706295.
      Citations: 3     Fields:    
    17. Qayyum A, Bhosale P, Aslam R, Avritscher R, Ma J, Pagel MD, Sun J, Mohamed Y, Rashid A, Beretta L, Kaseb AO. Effect of sarcopenia on systemic targeted therapy response in patients with advanced hepatocellular carcinoma. Abdom Radiol (NY). 2021 03; 46(3):1008-1015. PMID: 32974761; PMCID: PMC8191337.
      Citations: 4     Fields:    Translation:Humans
    18. Kwan SY, Jiao J, Qi J, Wang Y, Wei P, McCormick JB, Fisher-Hoch SP, Beretta L. Bile Acid Changes Associated With Liver Fibrosis and Steatosis in the Mexican-American Population of South Texas. Hepatol Commun. 2020 Apr; 4(4):555-568. PMID: 32258950; PMCID: PMC7109342.
      Citations: 7     Fields:    
    19. Saldarriaga OA, Freiberg B, Krishnan S, Rao A, Burks J, Booth AL, Dye B, Utay N, Ferguson M, Akil A, Yi M, Beretta L, Stevenson HL. Multispectral Imaging Enables Characterization of Intrahepatic Macrophages in Patients With Chronic Liver Disease. Hepatol Commun. 2020 May; 4(5):708-723. PMID: 32363321; PMCID: PMC7193134.
      Citations: 5     Fields:    
    20. Feng Z, Marrero JA, Khaderi S, Singal AG, Kanwal F, Loo N, Beretta L, Ning J, El-Serag HB. Design of the Texas Hepatocellular Carcinoma Consortium Cohort Study. Am J Gastroenterol. 2019 03; 114(3):530-532. PMID: 30699099.
      Citations: 11     Fields:    Translation:Humans
    21. Vriens K, Christen S, Parik S, Broekaert D, Yoshinaga K, Talebi A, Dehairs J, Escalona-Noguero C, Schmieder R, Cornfield T, Charlton C, Rossi M, Rinaldi G, Orth MF, Boon R, Kerstens A, Kwan SY, Faubert B, Kopitz CC, Chen T, Fernandez-Garcia J, Schmitz AA, Steigemann P, Van Ginderachter JA, Gotoh N, Wong KK, Verfaillie C, Derua R, Munck S, Yuneva M, Beretta L, DeBerardinis RJ, Swinnen JV, Hodson L, Cassiman D, Verslype C, Christian S, Fendt SM, Romero-P?rez L, M?ndez-Lucas A, Duarte JAG, Najimi M, H?gebarth A, Sokal E, Gr?newald S, Gr?newald TGP. Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity. Nature. 2019 02; 566(7744):403-406. PMID: 30728499; PMCID: PMC6390935.
      Citations: 107     Fields:    Translation:HumansAnimalsCells
    22. Nguyen J, Jiao J, Smoot K, Watt GP, Zhao C, Song X, Stevenson HL, McCormick JB, Fisher-Hoch SP, Zhang J, Futreal PA, Beretta L. Toll-like receptor 4: a target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitis. Oncotarget. 2018 Jun 29; 9(50):29495-29507. PMID: 30034633; PMCID: PMC6047684.
      Citations: 9     Fields:    
    23. Watt GP, Lee M, Pan JJ, Fallon MB, Loomba R, Beretta L, McCormick JB, Fisher-Hoch SP. High Prevalence of Hepatic Fibrosis, Measured by Elastography,?in a Population-Based Study of Mexican Americans. Clin Gastroenterol Hepatol. 2019 04; 17(5):968-975.e5. PMID: 29902644; PMCID: PMC6289899.
      Citations: 8     Fields:    Translation:Humans
    24. Jiao J, Watt GP, Stevenson HL, Calderone TL, Fisher-Hoch SP, Ye Y, Wu X, Vierling JM, Beretta L. Telomerase reverse transcriptase mutations in plasma DNA in patients with hepatocellular carcinoma or cirrhosis: Prevalence and risk factors. Hepatol Commun. 2018 Jun; 2(6):718-731. PMID: 29881823; PMCID: PMC5983165.
      Citations: 23     Fields:    
    25. Jiao J, Stevenson HL, Gagea M, Sugimoto H, Kalluri R, Beretta L, Gonz?lez ?. Depletion of S100A4+ stromal cells does not prevent HCC development but reduces the stem cell-like phenotype of the tumors. Exp Mol Med. 2018 01 05; 50(1):e422. PMID: 29303514; PMCID: PMC5992984.
      Citations: 10     Fields:    Translation:AnimalsCells
    26. Yoo W, Gjuka D, Stevenson HL, Song X, Shen H, Yoo SY, Wang J, Fallon M, Ioannou GN, Harrison SA, Beretta L. Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid. PLoS One. 2017; 12(12):e0189965. PMID: 29244873; PMCID: PMC5731750.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    27. Jiao J, Niu W, Wang Y, Baggerly K, Ye Y, Wu X, Davenport D, Almeda JL, Betancourt-Garcia MM, Forse RA, Stevenson HL, Watt GP, McCormick JB, Fisher-Hoch SP, Beretta L. Prevalence of Aflatoxin-Associated TP53R249S Mutation in Hepatocellular Carcinoma in Hispanics in South Texas. Cancer Prev Res (Phila). 2018 02; 11(2):103-112. PMID: 29089331; PMCID: PMC5811406.
      Citations: 11     Fields:    Translation:Humans
    28. Jung KH, Yoo W, Stevenson HL, Deshpande D, Shen H, Gagea M, Yoo SY, Wang J, Eckols TK, Bharadwaj U, Tweardy DJ, Beretta L. Multifunctional Effects of a Small-Molecule STAT3 Inhibitor on NASH and Hepatocellular Carcinoma in Mice. Clin Cancer Res. 2017 Sep 15; 23(18):5537-5546. PMID: 28533225; PMCID: PMC5873583.
      Citations: 28     Fields:    Translation:HumansAnimalsCells
    29. Watt GP, Vatcheva KP, Griffith DM, Reininger BM, Beretta L, Fallon MB, McCormick JB, Fisher-Hoch SP. The Precarious Health of Young Mexican American Men in South Texas, Cameron County Hispanic Cohort, 2004-2015. Prev Chronic Dis. 2016 08 25; 13:E113. PMID: 27560721; PMCID: PMC5003530.
      Citations: 9     Fields:    Translation:Humans
    30. Misra S, Stepien M, Plymoth A, Muller D, Overvad K, Olsen A, Baglietto L, Severi G, Boutron-Ruault MC, Turzanski-Fortner R, Kaaks R, Trichopoulou A, Lagiou P, Bamia C, Pala V, Palli D, Mattiello A, Tumino R, Naccarati A, Bueno-de-Mesquita HB, Peeters PH, Agudo A, Ardanaz E, Gavrila D, Dorronsoro M, Wareham NJ, Khaw KT, Bradbury KE, Gunter MJ, Cross AJ, Riboli E, Jenab M, Beretta L, Duarte-Salles T, Tj?nneland A, Boeing H, Aleksandrova K, Weiderpass E, Quir?s JR, S?nchez-Cantalejo E, Werner M, Hemmingsson O, Ohlsson B, Sj?berg K, Hainaut P. Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population. Cancer Prev Res (Phila). 2016 Sep; 9(9):758-65. PMID: 27339170; PMCID: PMC5010922.
      Citations: 23     Fields:    Translation:Humans
    31. Jiao J, Watt GP, Lee M, Rahbar MH, Vatcheva KP, Pan JJ, McCormick JB, Fisher-Hoch SP, Fallon MB, Beretta L. Cirrhosis and Advanced Fibrosis in Hispanics in Texas: The Dominant Contribution of Central Obesity. PLoS One. 2016; 11(3):e0150978. PMID: 26950933; PMCID: PMC4780836.
      Citations: 11     Fields:    Translation:Humans
    32. Jung KH, McCarthy RL, Zhou C, Uprety N, Barton MC, Beretta L. MicroRNA Regulates Hepatocytic Differentiation of Progenitor Cells by Targeting YAP1. Stem Cells. 2016 05; 34(5):1284-96. PMID: 26731713; PMCID: PMC4860085.
      Citations: 14     Fields:    Translation:HumansCells
    33. Pecorelli N, Carrara G, De Cobelli F, Cristel G, Damascelli A, Balzano G, Beretta L, Braga M. Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery. Br J Surg. 2016 Mar; 103(4):434-42. PMID: 26780231.
      Citations: 64     Fields:    Translation:Humans
    34. Jung KH, Zhang J, Zhou C, Shen H, Gagea M, Rodriguez-Aguayo C, Lopez-Berestein G, Sood AK, Beretta L. Differentiation therapy for hepatocellular carcinoma: Multifaceted effects of miR-148a on tumor growth and phenotype and liver fibrosis. Hepatology. 2016 Mar; 63(3):864-79. PMID: 26599259; PMCID: PMC4764447.
      Citations: 46     Fields:    Translation:HumansAnimalsCells
    35. Zou RH, Lin QG, Huang W, Li XL, Cao Y, Zhang J, Zhou JH, Li AH, Beretta L, Qian CN. Quantitative Contrast-Enhanced Ultrasonic Imaging Reflects Microvascularization in Hepatocellular Carcinoma and Prognosis after Resection. Ultrasound Med Biol. 2015 Oct; 41(10):2621-30. PMID: 26210785.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    36. Watt GP, Vatcheva KP, Beretta L, Pan JJ, Fallon MB, McCormick JB, Fisher-Hoch SP. Hepatitis C virus in Mexican Americans: a population-based study reveals relatively high prevalence and negative association with diabetes. Epidemiol Infect. 2016 Jan; 144(2):297-305. PMID: 26088260; PMCID: PMC5013540.
      Citations: 1     Fields:    Translation:HumansCells
    37. Pan JJ, Fisher-Hoch SP, Chen C, Feldstein AE, McCormick JB, Rahbar MH, Beretta L, Fallon MB. Burden of nonalcoholic fatty liver disease and advanced fibrosis in a Texas Hispanic community cohort. World J Hepatol. 2015 Jun 18; 7(11):1586-94. PMID: 26085918; PMCID: PMC4462697.
      Citations: 13     
    38. Zhang J, Jiao J, Cermelli S, Muir K, Jung KH, Zou R, Rashid A, Gagea M, Zabludoff S, Kalluri R, Beretta L. miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells. Cancer Res. 2015 May 01; 75(9):1859-67. PMID: 25769721; PMCID: PMC4603420.
      Citations: 35     Fields:    Translation:AnimalsCells
    39. da Costa AN, Plymoth A, Santos-Silva D, Ortiz-Cuaran S, Camey S, Guilloreau P, Sangrajrang S, Khuhaprema T, Mendy M, Lesi OA, Chang HK, Oh JK, Lee DH, Shin HR, Kirk GD, Merle P, Beretta L, Hainaut P. Osteopontin and latent-TGF ? binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma. Int J Cancer. 2015 Jan 01; 136(1):172-81. PMID: 24803312; PMCID: PMC4617682.
      Citations: 31     Fields:    Translation:Humans
    40. Muir K, Hazim A, He Y, Peyressatre M, Kim DY, Song X, Beretta L. Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma. Cancer Res. 2013 Aug 01; 73(15):4722-31. PMID: 23749645; PMCID: PMC3855016.
      Citations: 71     Fields:    Translation:HumansAnimals
    41. Broen JC, Bossini-Castillo L, van Bon L, Vonk MC, Knaapen H, Beretta L, Rueda B, Hesselstrand R, Herrick A, Worthington J, Hunzelman N, Denton CP, Fonseca C, Riemekasten G, Kiener HP, Scorza R, Ortego-Centeno N, Gonzalez-Gay MA, Coenen MJ, Radstake TR, Spanish Systemic Sclerosis Group, Sime?n CP, Air? P, Mart?n J. A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators. Arthritis Rheum. 2012 Jan; 64(1):264-71. PMID: 21905008.
      Citations: 32     Fields:    Translation:HumansCells
    42. Shang S, Plymoth A, Ge S, Feng Z, Rosen HR, Sangrajrang S, Hainaut P, Marrero JA, Beretta L. Identification of osteopontin as a novel marker for early hepatocellular carcinoma. Hepatology. 2012 Feb; 55(2):483-90. PMID: 21953299; PMCID: PMC3914762.
      Citations: 138     Fields:    Translation:Humans
    43. Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L. Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One. 2011; 6(8):e23937. PMID: 21886843; PMCID: PMC3160337.
      Citations: 240     Fields:    Translation:Humans
    44. Lai KK, Shang S, Lohia N, Booth GC, Masse DJ, Fausto N, Campbell JS, Beretta L. Extracellular matrix dynamics in hepatocarcinogenesis: a comparative proteomics study of PDGFC transgenic and Pten null mouse models. PLoS Genet. 2011 Jun; 7(6):e1002147. PMID: 21731504; PMCID: PMC3121762.
      Citations: 48     Fields:    Translation:AnimalsCells
    45. Parent R, Qu X, Petit MA, Beretta L. The heat shock cognate protein 70 is associated with hepatitis C virus particles and modulates virus infectivity. Hepatology. 2009 Jun; 49(6):1798-809. PMID: 19434724; PMCID: PMC4605602.
      Citations: 36     Fields:    Translation:Cells
    46. Lee NP, Chen L, Lin MC, Tsang FH, Yeung C, Poon RT, Peng J, Leng X, Beretta L, Sun S, Day PJ, Luk JM. Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma. J Proteome Res. 2009 Mar; 8(3):1293-303. PMID: 19161326; PMCID: PMC4617681.
      Citations: 27     Fields:    Translation:Humans
    47. Beretta L. Comparative analysis of the liver and plasma proteomes as a novel and powerful strategy for hepatocellular carcinoma biomarker discovery. Cancer Lett. 2009 Dec 01; 286(1):134-9. PMID: 19232462; PMCID: PMC4601561.
      Citations: 6     Fields:    Translation:HumansAnimals
    48. Olson KE, Booth GC, Poulin F, Sonenberg N, Beretta L. Impaired myelopoiesis in mice lacking the repressors of translation initiation, 4E-BP1 and 4E-BP2. Immunology. 2009 Sep; 128(1 Suppl):e376-84. PMID: 19175792; PMCID: PMC2753918.
      Citations: 8     Fields:    Translation:AnimalsCells
    49. Lai KK, Kolippakkam D, Beretta L. Comprehensive and quantitative proteome profiling of the mouse liver and plasma. Hepatology. 2008 Mar; 47(3):1043-51. PMID: 18266228.
      Citations: 27     Fields:    Translation:AnimalsCells
    50. Parent R, Beretta L. Translational control plays a prominent role in the hepatocytic differentiation of HepaRG liver progenitor cells. Genome Biol. 2008 Jan 25; 9(1):R19. PMID: 18221535; PMCID: PMC2395229.
      Citations: 21     Fields:    Translation:HumansCells
    51. Yi X, Luk JM, Lee NP, Peng J, Leng X, Guan XY, Lau GK, Beretta L, Fan ST. Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. Mol Cell Proteomics. 2008 Feb; 7(2):315-25. PMID: 17934217.
      Citations: 54     Fields:    Translation:HumansAnimalsCells
    52. Ioannou GN, Splan MF, Weiss NS, McDonald GB, Beretta L, Lee SP. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol. 2007 Aug; 5(8):938-45, 945.e1-4. PMID: 17509946.
      Citations: 85     Fields:    Translation:HumansCells
    53. Parent R, Kolippakkam D, Booth G, Beretta L. Mammalian target of rapamycin activation impairs hepatocytic differentiation and targets genes moderating lipid homeostasis and hepatocellular growth. Cancer Res. 2007 May 01; 67(9):4337-45. PMID: 17483347.
      Citations: 17     Fields:    Translation:HumansCells
    54. Fang R, Wang H, Deng B, McIntosh MW, Hanash SM, Beretta L, Mannov? P. Modification of host lipid raft proteome upon hepatitis C virus replication. Mol Cell Proteomics. 2006 Dec; 5(12):2319-25. PMID: 16943187.
      Citations: 39     Fields:    Translation:HumansCells
    55. Feng JT, Shang S, Beretta L. Proteomics for the early detection and treatment of hepatocellular carcinoma. Oncogene. 2006 Jun 26; 25(27):3810-7. PMID: 16799622.
      Citations: 19     Fields:    Translation:HumansAnimals
    56. Chignard N, Shang S, Wang H, Marrero J, Hanash S, Beretta L, Br?chot C. Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma: Detection of generated fragments in patient sera. Gastroenterology. 2006 Jun; 130(7):2010-22. PMID: 16762624.
      Citations: 19     Fields:    Translation:HumansCells
    57. Parent R, Beretta L. Proteomics in the study of liver pathology. J Hepatol. 2005 Jul; 43(1):177-83. PMID: 15894398.
      Citations: 8     Fields:    Translation:HumansAnimals
    58. Chignard N, Beretta L. Proteomics for hepatocellular carcinoma marker discovery. Gastroenterology. 2004 Nov; 127(5 Suppl 1):S120-5. PMID: 15508075.
      Citations: 16     Fields:    Translation:HumansPHPublic Health
    59. Girard S, Vossman E, Misek DE, Podevin P, Hanash S, Beretta L, Br?chot C. Hepatitis C virus NS5A-regulated gene expression and signaling revealed via microarray and comparative promoter analyses. Hepatology. 2004 Sep; 40(3):708-18. PMID: 15349911.
      Citations: 11     Fields:    Translation:HumansCells
    60. Barnes BJ, Richards J, Mancl M, Hanash S, Beretta L, Pitha PM. Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J Biol Chem. 2004 Oct 22; 279(43):45194-207. PMID: 15308637.
      Citations: 106     Fields:    Translation:HumansCells
    61. Beretta L. Translational control in T lymphocytes. Int Rev Immunol. 2004 May-Aug; 23(3-4):347-63. PMID: 15204093.
      Citations: 2     Fields:    Translation:HumansCells
    62. Baraban JM, Grolleau A, Beretta L, Dy M, Rolli-Derkinderen M, Machavoine F. ERK and p38 inhibit the expression of 4E-BP1 repressor of translation through induction of Egr-1. J Biol Chem. 2003 May 23; 278(21):18859-67. PMID: 12618431.
      Citations: 21     Fields:    Translation:HumansCells
    63. Richards J, Le Naour F, Hanash S, Beretta L. Integrated genomic and proteomic analysis of signaling pathways in dendritic cell differentiation and maturation. Ann N Y Acad Sci. 2002 Dec; 975:91-100. PMID: 12538157.
      Citations: 16     Fields:    Translation:HumansAnimalsCells
    64. Brichory F, Beretta L, Hanash SM, Naour FL. Identification of tumor-associated antigens using proteomics. Technol Cancer Res Treat. 2002 Aug; 1(4):257-62. PMID: 12625784.
      Citations: 8     Fields:    Translation:Humans
    65. Singer NG, Fox DA, Haqqi TM, Beretta L, Endres JS, Prohaska S, Parnes JR, Bromberg J, Sramkoski RM. CD6: expression during development, apoptosis and selection of human and mouse thymocytes. Int Immunol. 2002 Jun; 14(6):585-97. PMID: 12039910.
      Citations: 26     Fields:    Translation:HumansAnimalsCells
    66. Girard S, Shalhoub P, Lescure P, Sabile A, Misek DE, Hanash S, Beretta L, Br?chot C. An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis. Virology. 2002 Apr 10; 295(2):272-83. PMID: 12033786.
      Citations: 18     Fields:    Translation:HumansCells
    67. Grolleau A, Bowman J, Puravs E, Hanash S, Garcia-Sanz JA, Beretta L, Pradet-Balade B. Global and specific translational control by rapamycin in T cells uncovered by microarrays and proteomics. J Biol Chem. 2002 Jun 21; 277(25):22175-84. PMID: 11943782.
      Citations: 72     Fields:    Translation:HumansCells
    68. Brichory F, Misek DE, Hanash SM, Beretta L, Le Naour F, Br?chot C. A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis. Mol Cell Proteomics. 2002 Mar; 1(3):197-203. PMID: 12096119.
      Citations: 42     Fields:    Translation:Humans
    69. Hanash SM, Beretta LM. Operomics: integrated genomic and proteomic profiling of cells and tissues. Brief Funct Genomic Proteomic. 2002 Feb; 1(1):10-22. PMID: 15251063.
      Citations: 2     Fields:    Translation:HumansCells
    70. Dua K, Williams TM, Beretta L. Translational control of the proteome: relevance to cancer. Proteomics. 2001 Oct; 1(10):1191-9. PMID: 11721631.
      Citations: 12     Fields:    Translation:HumansCells
    71. Le Naour F, Hohenkirk L, Grolleau A, Misek DE, Lescure P, Geiger JD, Hanash S, Beretta L. Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics. J Biol Chem. 2001 May 25; 276(21):17920-31. PMID: 11279020.
      Citations: 81     Fields:    Translation:HumansCells
    72. Shalhoub P, Kern S, Girard S, Beretta L. Proteomic-based approach for the identification of tumor markers associated with hepatocellular carcinoma. Dis Markers. 2001; 17(4):217-23. PMID: 11790889; PMCID: PMC3851642.
      Citations: 2     Fields:    Translation:Humans
    73. Kaplan MJ, Hanash SM, Beretta L, Richardson B, Grolleau A. Impaired translational response and increased protein kinase PKR expression in T cells from lupus patients. J Clin Invest. 2000 Dec; 106(12):1561-8. PMID: 11120763; PMCID: PMC381471.
      Citations: 16     Fields:    Translation:HumansCells
    74. Grolleau A, Wietzerbin J, Beretta L. Defect in the regulation of 4E-BP1 and 2, two repressors of translation initiation, in the retinoid acid resistant cell lines, NB4-R1 and NB4-R2. Leukemia. 2000 Nov; 14(11):1909-14. PMID: 11069026.
      Citations: 4     Fields:    Translation:HumansCells
    75. Meucci G, Vecchi M, Astegiano M, Beretta L, Cesari P, Dizioli P, Ferraris L, Panelli MR, Prada A, Sostegni R, de Franchis R. The natural history of ulcerative proctitis: a multicenter, retrospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII). Am J Gastroenterol. 2000 Feb; 95(2):469-73. PMID: 10685752.
      Citations: 33     Fields:    Translation:Humans
    76. Sonenberg N, Wietzerbin J, Beretta L, Grolleau A. Differential regulation of 4E-BP1 and 4E-BP2, two repressors of translation initiation, during human myeloid cell differentiation. J Immunol. 1999 Mar 15; 162(6):3491-7. PMID: 10092805.
      Citations: 16     Fields:    Translation:HumansCells
    77. Beretta L, Singer NG, Hinderer R, Gingras AC, Richardson B, Hanash SM, Sonenberg N. Differential regulation of translation and eIF4E phosphorylation during human thymocyte maturation. J Immunol. 1998 Apr 01; 160(7):3269-73. PMID: 9531283.
      Citations: 9     Fields:    Translation:HumansCells
    78. Gabbay M, Berger R, Hanash SM, Sonenberg N, Beretta L. Expression of the protein kinase PKR in modulated by IRF-1 and is reduced in 5q- associated leukemias. Oncogene. 1996 Apr 04; 12(7):1593-6. PMID: 8622878.
      Citations: 19     Fields:    Translation:HumansCells
    79. Gavazzi A, De Maria R, Porcu M, Beretta L, Casazza F, Castelli G, Luvini M, Parodi O, Recalcati F, Renosto G, et al. [Dilated cardiomyopathy: a new natural history? The experience of the Italian Multicenter Cardiomyopathy Study (SPIC)]. G Ital Cardiol. 1995 Sep; 25(9):1109-25. PMID: 8529848.
      Citations: 3     Fields:    Translation:Humans
    80. Primignani M, Andreoni B, Carpinelli L, Capria A, Rocchi G, Lorenzini I, Staudacher C, Beretta L, Motta R, de Franchis R. Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal varices: a randomized, double-blind, placebo-controlled, multicenter trial. New Italian Endoscopic Club. Hepatology. 1995 May; 21(5):1322-7. PMID: 7737638.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    81. Hanash SM, Beretta L, Barcroft CL, Sheldon S, Glover TW, Ungar D, Sonenberg N. Mapping of the gene for interferon-inducible dsRNA-dependent protein kinase to chromosome region 2p21-22: a site of rearrangements in myeloproliferative disorders. Genes Chromosomes Cancer. 1993 Sep; 8(1):34-7. PMID: 7691157.
      Citations: 4     Fields:    Translation:HumansCells
    82. The precarious health of young Mexican American men in South Texas, cameron county hispanic cohort, 2004-2015. Preventing chronic disease. 13.
    83. Burden of nonalcoholic fatty liver disease and advanced fibrosis in a Texas Hispanic community cohort. World Journal of Hepatology. 7:1586-1594.
    84. Barbados Conference 2007. Molecular and Cellular Proteomics. 6:1287-1288.
    85. Cirrhosis and advanced fibrosis in Hispanics in Texas. PLoS One. 11.
    86. Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population. Cancer Prevention Research. 9:758-765.
    87. Differentiation therapy for hepatocellular carcinoma. Hepatology.
    88. Liver proteomics applied to translational research in liver disease and cancer. Proteomics - Clinical Applications. 4:362-371.
    89. La rapamycine. Medecine/Sciences. 14:600-602.
    90. Biology of the Cell. 76:215.
    91. The Liver Proteome. 961-963.
    92. MicroRNA Regulates Hepatocytic Differentiation of Progenitor Cells by Targeting YAP1. Stem Cells. 34:1284-1296.
    BERETTA's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (417)
    Co-Authors (47)
    Similar People (60)
    Same Department Expand Description